ATLAS / Macro Radar / Reporting / CADL

Candel Therapeutics, Inc. (CADL) reporting calendar

Candel Therapeutics, Inc. files periodic reports with the SEC as CADL on Nasdaq. Atlas tracks 20 filed reports for this issuer, each linked to its original EDGAR accession.

Next window
30 Jul 2026 – 27 Aug 2026
Latest report
10-Q
Period ended
31 Mar 2026
Filed
14 May 2026
Reports on record
20

How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 44 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.

Filed periodic reports

FormPeriod endedFiledLagSEC accession
10-Q31 Mar 202614 May 202644 days0001193125-26-222904
10-K31 Dec 202512 Mar 202671 days0001193125-26-103134
10-Q30 Sep 202513 Nov 202544 days0001193125-25-279086
10-Q30 Jun 202514 Aug 202545 days0000950170-25-108450
10-Q31 Mar 202513 May 202543 days0000950170-25-069833
10-K31 Dec 202413 Mar 202572 days0000950170-25-038803
10-Q30 Sep 202414 Nov 202445 days0000950170-24-126767
10-Q30 Jun 202413 Aug 202444 days0000950170-24-095784
10-Q31 Mar 202414 May 202444 days0000950170-24-059118
10-K31 Dec 202328 Mar 202488 days0000950170-24-037637
10-Q30 Sep 20239 Nov 202340 days0000950170-23-061566
10-Q30 Jun 202310 Aug 202341 days0000950170-23-040984
10-Q31 Mar 202311 May 202341 days0000950170-23-020873
10-K31 Dec 202230 Mar 202389 days0000950170-23-010760
10-Q30 Sep 202210 Nov 202241 days0000950170-22-024197
10-Q30 Jun 20225 Aug 202236 days0000950170-22-014970
10-Q31 Mar 202212 May 202242 days0000950170-22-009479
10-K31 Dec 202129 Mar 202288 days0000950170-22-004857
10-Q30 Sep 202112 Nov 202143 days0000950170-21-004274
10-Q30 Jun 20218 Sep 202170 days0001564590-21-047259

Source: SEC EDGAR company submissions for CIK 0001841387. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.